Cargando…
The effect of comorbidities on the choice of tyrosine kinase inhibitors in patients with chronic myeloid leukemia
Tyrosine kinase inhibitors (TKIs) approved for chronic myeloid leukemia known to have similar efficacies but different safety profiles. Therefore, the choice of patient-specific treatments is driven by factors such as tolerability and adverse event profile of TKIs. This review article examines the m...
Autores principales: | Saydam, Guray, Ali, Ridvan, Demir, Ahmet Muzaffer, Eskazan, Ahmet Emre, Guvenc, Birol, Haznedaroglu, Ibrahim Celalettin, Ozcan, Mehmet Ali, Salim, Ozan, Sonmez, Mehmet, Tuglular, Ayse Tulin, Turgut, Mehmet, Unal, Ali, Aver, Birkan, Bozkurt, Sirac, Ozdengulsun, Begum, Ilhan, Osman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9136639/ https://www.ncbi.nlm.nih.gov/pubmed/35664044 http://dx.doi.org/10.2217/ijh-2021-0010 |
Ejemplares similares
-
Turkey real-life data: demographic features, treatment results and effects of comorbidities in chronic myeloid leukemia
por: Saydam, Guray, et al.
Publicado: (2022) -
Efficacy and safety of ruxolitinib in patients with myelofibrosis: a retrospective and multicenter experience in Turkey
por: SOYER, Nur, et al.
Publicado: (2021) -
Patterns of Hydroxyurea Prescription and Use in Routine Clinical Management of Polycythemia Vera: A Multicenter Chart Review Study
por: Büyükaşık, Yahya, et al.
Publicado: (2020) -
Exercise-Induced Right Ventricular Outflow Tract Tachycardia in a Patient with Isolated Left Ventricular Noncompaction
por: Güvenç, Tolga Sinan, et al.
Publicado: (2011) -
Multicenter Retrospective Analysis of Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Soyer, Nur, et al.
Publicado: (2017)